| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Oncolytics Biotech Inc (NASDAQ: ONCY)
ONCY Technical Analysis
1.5
| As on 9th Jun 2023 ONCY SHARE Price closed @ 1.55 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.37 & Sell for SHORT-TERM with Stoploss of 1.67 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ONCYSHARE Price
| Open | 1.59 | Change | Price | % |
| High | 1.59 | 1 Day | -0.03 | -1.90 |
| Low | 1.52 | 1 Week | -0.20 | -11.43 |
| Close | 1.55 | 1 Month | 0.42 | 37.17 |
| Volume | 312831 | 1 Year | 0.06 | 4.03 |
| 52 Week High 2.16 | 52 Week Low 0.85 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ONCY Daily Charts |
ONCY Intraday Charts |
Whats New @ Bazaartrend |
ONCY Free Analysis |
|
|
ONCY Important Levels Intraday
| RESISTANCE | 1.68 |
| RESISTANCE | 1.64 |
| RESISTANCE | 1.61 |
| RESISTANCE | 1.59 |
| SUPPORT | 1.51 |
| SUPPORT | 1.49 |
| SUPPORT | 1.46 |
| SUPPORT | 1.42 |
ONCY Forecast April 2024
| 4th UP Forecast | 3.15 |
| 3rd UP Forecast | 2.64 |
| 2nd UP Forecast | 2.32 |
| 1st UP Forecast | 2 |
| 1st DOWN Forecast | 1.1 |
| 2nd DOWN Forecast | 0.78 |
| 3rd DOWN Forecast | 0.46 |
| 4th DOWN Forecast | -0.05 |
ONCY Weekly Forecast
| 4th UP Forecast | 1.86 |
| 3rd UP Forecast | 1.76 |
| 2nd UP Forecast | 1.70 |
| 1st UP Forecast | 1.64 |
| 1st DOWN Forecast | 1.46 |
| 2nd DOWN Forecast | 1.40 |
| 3rd DOWN Forecast | 1.34 |
| 4th DOWN Forecast | 1.24 |
ONCY Forecast2024
| 4th UP Forecast | 4.4 |
| 3rd UP Forecast | 3.49 |
| 2nd UP Forecast | 2.92 |
| 1st UP Forecast | 2.36 |
| 1st DOWN Forecast | 0.74 |
| 2nd DOWN Forecast | 0.18 |
| 3rd DOWN Forecast | -0.39 |
| 4th DOWN Forecast | -1.3 |
Oncolytics Biotech Inc ( NASDAQ USA Symbol : ONCY )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ONCY Business Profile
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an immuno-oncology viral-agent for the treatment of solid tumors and hematological malignancies. The company has collaboration agreements with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone-receptor positive, human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada. Address: 1167 Kensington Crescent NW, Calgary, AB, Canada, T2N 1X7
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service